CapForce IBD 50 ETF
FFTY
70 hedge funds and large institutions have $92.9M invested in CapForce IBD 50 ETF in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 7 closing their positions.
519% more call options, than puts
Call options by funds: $1.98M | Put options by funds: $320K
45% more capital invested
Capital invested by funds: $64M → $92.9M (+$28.9M)
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
9.48% more ownership
Funds ownership: 26.44% → 35.92% (+9.5%)
3% more funds holding
Funds holding: 68 → 70 (+2)
0% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.1M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.35M |
| 3 |
ACM
Avalon Capital Management
Port Of Redwood City,
California
|
+$5.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.19M |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$1.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.85M |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.51M |
| 3 |
FTUS
Flow Traders U.S.
New York
|
-$1.38M |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$1M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$345K |
FFTY Hedge Fund Activity: Q3 2021 in Review
70 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q3 2021, worth a combined $92.9M — up 45% from $64M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new FFTY positions and 7 closed out — a net gain of 3 holders — while 21 added to existing stakes and 21 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $14.1M. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.85M.
- 70 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q3 2021, up from 68 in Q2 2021.
- Funds reported $92.9M of CapForce IBD 50 ETF stock for Q3 2021, up 45% quarter-over-quarter.
- 10 funds opened new CapForce IBD 50 ETF positions in Q3 2021 and 7 closed out, a net change of +3 holders.
- The largest CapForce IBD 50 ETF buyer in Q3 2021 was Susquehanna International Group, an estimated $14.1M added.
- The largest CapForce IBD 50 ETF seller in Q3 2021 was Tower Research Capital (TRC), an estimated $1.85M sold.
Based on aggregated 13F filings for Q3 2021.